PNC Financial Services Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.7K Buy
8,310
+1,165
+16% +$4.63K ﹤0.01% 3502
2025
Q4
$25.1K Buy
7,145
+637
+10% +$2.18K ﹤0.01% 3564
2025
Q3
$21.2K Sell
6,508
-4,259
-40% -$13.4K ﹤0.01% 3610
2025
Q2
$26.4K Sell
10,767
-9,897
-48% -$50.1K ﹤0.01% 3437
2025
Q1
$138K Sell
20,664
-1,791
-8% -$17.7K ﹤0.01% 2442
2024
Q4
$282K Buy
22,455
+6,342
+39% +$95.5K ﹤0.01% 1956
2024
Q3
$298K Buy
16,113
+577
+4% +$11.8K ﹤0.01% 1909
2024
Q2
$334K Buy
15,536
+768
+5% +$17.6K ﹤0.01% 1792
2024
Q1
$398K Sell
14,768
-583
-4% -$16.6K ﹤0.01% 1679
2023
Q4
$460K Sell
15,351
-1,495
-9% -$33K ﹤0.01% 1573
2023
Q3
$345K Buy
16,846
+2,014
+14% +$36.6K ﹤0.01% 1735
2023
Q2
$295K Buy
14,832
+480
+3% +$9.7K ﹤0.01% 1936
2023
Q1
$246K Buy
14,352
+89
+0.6% +$1.74K ﹤0.01% 2011
2022
Q4
$279K Buy
14,263
+1,955
+16% +$36K ﹤0.01% 1911
2022
Q3
$196K Buy
12,308
+657
+6% +$10.3K ﹤0.01% 2098
2022
Q2
$161K Buy
11,651
+3,390
+41% +$40.4K ﹤0.01% 2277
2022
Q1
$131K Sell
8,261
-29
-0.3% -$501 ﹤0.01% 2540
2021
Q4
$182K Sell
8,290
-347
-4% -$9.47K ﹤0.01% 2305
2021
Q3
$259K Buy
8,637
+340
+4% +$12.4K ﹤0.01% 2023
2021
Q2
$368K Buy
8,297
+651
+9% +$28.3K ﹤0.01% 1818
2021
Q1
$338K Sell
7,646
-905
-11% -$49.7K ﹤0.01% 1840
2020
Q4
$468K Sell
8,551
-429
-5% -$15.6K ﹤0.01% 1523
2020
Q3
$206K Hold
8,980
﹤0.01% 1913
2020
Q2
$188K Sell
8,980
-620
-6% -$11.2K ﹤0.01% 1966
2020
Q1
$134K Buy
+9,600
New +$190K ﹤0.01% 2044

Other funds holding RCKT